Abstract:Objective
The COVID-19 pandemic increased economic, social, and health stressors for families, yet its impacts on families of youth with chronic conditions, such as type 1 diabetes (T1D), are not well understood. Self-regulation (SR)—or the capacities to control emotions, cognition, and behavior in response to challenge—is known to support T1D management and coping in the face of stress. Strong SR may have protected youth with T1D from the impacts of pandemic-related stressors. This study com… Show more
“…The average anxiety levels varied from minimal [37,44,47,50,56,58,61], to mild [26,36,52], to moderate [62], to severe [39]. For diabetes distress, the mean levels were low [31,45,47,55,58], moderate [33,52,60], and high [29,54].…”
Section: Mean Levels Of Anxiety Distress and Stressmentioning
confidence: 98%
“…For diabetes distress, the mean levels were low [31,45,47,55,58], moderate [33,52,60], and high [29,54]. The mean stress levels found ranged from minimal [50,56,57,59], moderate [35,39,40,43,49,52,62], and high [46].…”
Section: Mean Levels Of Anxiety Distress and Stressmentioning
The prevalence of mental health disorders has increased during the COVID-19 pandemic. Patients with chronic diseases, such as diabetes, are a particularly vulnerable risk group. This study aims to assess the levels and prevalence of anxiety, distress, and stress in patients with diabetes during the COVID-19 pandemic. A systematic review was conducted in CINAHL, Cochrane, LILACS, Medline, SciELO, and Scopus in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Thirty-seven articles with a total of 13,932 diabetic patients were included. Five meta-analyses were performed. The prevalence of anxiety was 23% (95% CI = 19–28) in T1DM and 20% (95% CI = 6–40) in T2DM patients. For diabetes distress it was 41% (95% CI = 24–60) for T1DM and 36% in T2DM patients (95% CI = 2–84). For stress, the prevalence was 79% (95% CI = 49–98) in T1DM patients. People with diabetes have significant psychiatric comorbidity as well as psychological factors that negatively affect disease management, increasing their vulnerability in an emergency situation. To establish comprehensive care in diabetic patients addressing mental health is essential, as well as including specific policy interventions to reduce the potential psychological harm of the COVID-19 pandemic.
“…The average anxiety levels varied from minimal [37,44,47,50,56,58,61], to mild [26,36,52], to moderate [62], to severe [39]. For diabetes distress, the mean levels were low [31,45,47,55,58], moderate [33,52,60], and high [29,54].…”
Section: Mean Levels Of Anxiety Distress and Stressmentioning
confidence: 98%
“…For diabetes distress, the mean levels were low [31,45,47,55,58], moderate [33,52,60], and high [29,54]. The mean stress levels found ranged from minimal [50,56,57,59], moderate [35,39,40,43,49,52,62], and high [46].…”
Section: Mean Levels Of Anxiety Distress and Stressmentioning
The prevalence of mental health disorders has increased during the COVID-19 pandemic. Patients with chronic diseases, such as diabetes, are a particularly vulnerable risk group. This study aims to assess the levels and prevalence of anxiety, distress, and stress in patients with diabetes during the COVID-19 pandemic. A systematic review was conducted in CINAHL, Cochrane, LILACS, Medline, SciELO, and Scopus in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Thirty-seven articles with a total of 13,932 diabetic patients were included. Five meta-analyses were performed. The prevalence of anxiety was 23% (95% CI = 19–28) in T1DM and 20% (95% CI = 6–40) in T2DM patients. For diabetes distress it was 41% (95% CI = 24–60) for T1DM and 36% in T2DM patients (95% CI = 2–84). For stress, the prevalence was 79% (95% CI = 49–98) in T1DM patients. People with diabetes have significant psychiatric comorbidity as well as psychological factors that negatively affect disease management, increasing their vulnerability in an emergency situation. To establish comprehensive care in diabetic patients addressing mental health is essential, as well as including specific policy interventions to reduce the potential psychological harm of the COVID-19 pandemic.
Mitigating the effects of COVID-19 on child development involves understanding the impact of the pandemic on caregiver well-being and factors that protect against stress associated with the virus and measures used to reduce disease transmission. Mindfulness has become popularized in the West, with promising evidence that it may reduce caregiver stress. There is limited research examining the specific elements of mindfulness as it relates to caregiving instead of studying mindfulness as a singular construct. We examined whether the number of COVID-related stressors was related to caregivers’ stress, and whether this stress was reduced by their reported level of mindfulness. We examined whether four mindfulness processes: self-compassion, nonreactivity, nonjudging, and acting with awareness – buffered the impact of stressors on caregivers’ stress one month later in a sample of caregivers in the United States (N = 330). When accounting for other mindfulness processes, acting with awareness was the only significant moderator of COVID-related stressors and caregivers’ stress one month later. We discuss implications for recommendations to mitigate the effects of COVID-19 on caregivers’ stress through reducing stress and thus promoting well-being in caregivers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.